Until Monday, "Cythera" was known more as a computer game than as the name of a biotechnology company.
But CyThera Inc, which has no connection to the computer game, is overshadowed no more. The company, which was not known to be working on human embryonic stem cells, turns out to have derived nine colonies of such cells, according to a list released by the National Institutes of Health on Monday. That is more than other organizations better known for stem cells, such as the University of Wisconsin -- and second only to Goteborg University in Sweden, which has 19, according to the NIH list of stem-cell lines that will be eligible for use by federally financed scientists.
That could mean that CyThera will be sought out by academic scientists who are anxious to begin work on cells that they think can be used to grow heart, brain, liver and other cells to repair damaged organs. But CyThera, based in San Diego, said it is not quite ready for the limelight. It is privately held, with only US$2 million in venture financing, and it has only 10 employees.
"We're sort of blushing brides here," said Michael J. Ross, the company's president and chief executive.
The company's goal is to grow insulin-producing pancreas cells that can be implanted in patients to treat diabetes. But until now the company has not publicized the fact that it is using embryonic stem cells in its research.
"When I saw on that list that they had all those stem-cell lines, I was surprised," said Susan Bonner-Weir, an expert on diabetes cell therapy at the Joslin Diabetes Center in Boston and Harvard Medical School.
Ross said CyThera kept quiet because there was "no advantage to publicity, especially in an area that some people consider controversial."
But when it became clear, he said, that the NIH was drawing up its list of laboratories with stem cells, the company realized it should get on the list so it would be able to share its cells with academic scientists in the future.
But CyThera executives said it will be months, maybe longer, before the company is ready to provide cells to researchers. The company, which is worried about being overwhelmed by requests for cells, said it first needs to better characterize the properties of the cells it has.
Ross said CyThera has so many cell lines because the company was trying to find a different way to derive stem cells from the method used at the University of Wisconsin, where the first human embryonic stem cells were isolated three years ago.
"We weren't just trying to derive cell lines," he said. "We were trying to derive cell lines that are independent, and improve the techniques."
Ross said CyThera's method differs from Wisconsin's not in the way cells are obtained -- from discarded embryos at fertility clinics -- but in the way the cells are cultured.
He said he thinks the cells might avoid infringing Wisconsin's stem-cell patent, though that is not clear. Commercial rights to develop pancreatic cells under the Wisconsin patent have been licensed to Geron Corp of Menlo Park, California.
Doctors in Edmonton, Alberta, last year showed great success in weaning about a dozen diabetics from insulin injections by using cells derived from cadavers. That means that when CyThera does have some cells ready for transplant, it will already know how many cells are needed and where best to transplant them, taking some of the risk out of the clinical trials. CyThera is now trying to raise an additional US$8 million. It will take tens of millions of dollars and several years to advance to early clinical trials, in which the company will try to prove that the concept can work.
There are other companies working on a variety of cell therapies for diabetes. These include Curis of Cambridge, Massachusetts; Theracyte Inc of Irvine, California; and Islet Sheet Medical LLC of San Francisco.
NO-LIMITS PARTNERSHIP: ‘The bottom line’ is that if the US were to have a conflict with China or Russia it would likely open up a second front with the other, a US senator said Beijing and Moscow could cooperate in a conflict over Taiwan, the top US intelligence chief told the US Senate this week. “We see China and Russia, for the first time, exercising together in relation to Taiwan and recognizing that this is a place where China definitely wants Russia to be working with them, and we see no reason why they wouldn’t,” US Director of National Intelligence Avril Haines told a US Senate Committee on Armed Services hearing on Thursday. US Senator Mike Rounds asked Haines about such a potential scenario. He also asked US Defense Intelligence Agency Director Lieutenant General Jeffrey Kruse
INSPIRING: Taiwan has been a model in the Asia-Pacific region with its democratic transition, free and fair elections and open society, the vice president-elect said Taiwan can play a leadership role in the Asia-Pacific region, vice president-elect Hsiao Bi-khim (蕭美琴) told a forum in Taipei yesterday, highlighting the nation’s resilience in the face of geopolitical challenges. “Not only can Taiwan help, but Taiwan can lead ... not only can Taiwan play a leadership role, but Taiwan’s leadership is important to the world,” Hsiao told the annual forum hosted by the Center for Asia-Pacific Resilience and Innovation think tank. Hsiao thanked Taiwan’s international friends for their long-term support, citing the example of US President Joe Biden last month signing into law a bill to provide aid to Taiwan,
China’s intrusive and territorial claims in the Indo-Pacific region are “illegal, coercive, aggressive and deceptive,” new US Indo-Pacific Commander Admiral Samuel Paparo said on Friday, adding that he would continue working with allies and partners to keep the area free and open. Paparo made the remarks at a change-of-command ceremony at Joint Base Pearl Harbor-Hickam in Hawaii, where he took over the command from Admiral John Aquilino. “Our world faces a complex problem set in the troubling actions of the People’s Republic of China [PRC] and its rapid buildup of forces. We must be ready to answer the PRC’s increasingly intrusive and
STATE OF THE NATION: The legislature should invite the president to deliver an address every year, the TPP said, adding that Lai should also have to answer legislators’ questions The Chinese Nationalist Party (KMT) yesterday proposed inviting president-elect William Lai (賴清德) to make a historic first state of the nation address at the legislature following his inauguration on May 20. Lai is expected to face many domestic and international challenges, and should clarify his intended policies with the public’s representatives, KMT caucus secretary-general Hung Meng-kai (洪孟楷) said when making the proposal at a meeting of the legislature’s Procedure Committee. The committee voted to add the item to the agenda for Friday, along with another similar proposal put forward by the Taiwan People’s Party (TPP). The invitation is in line with Article 15-2